Michael Bogenschutz, MD, explains how psychedelic-assisted treatments may offer new options for patients with severe, treatment-refractory psychiatric conditions. He discusses why standard approaches often fall short for complex cases, how psychedelics like psilocybin and MDMA differ from conventional medications, and what careful screening and clinical structure make these treatments safe and effective. Drawing on randomized clinical trials and years of clinical experience, Dr. Bogenschutz d...
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Closing the Revolving Door of Severe Mental Illness
Diagnosing Autoimmune Psychosis
The Neuropsychiatry of Complex Brain Injury Care
Treating ADHD in Patients With Bipolar Disorder and Substance Use
Free AI-powered recaps of NYU Langone Insights on Psychiatry and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.